Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21.

View in: PubMed

subject areas

3-Iodobenzylguanidine
Acetylation
Adolescent
Adult
Aged
Child
Child, Preschool
Drug Monitoring
Female
Histones
Humans
Hydroxamic Acids
Iodine Radioisotopes
Male
Middle Aged
Neoplasm Recurrence, Local
Neuroblastoma
Norepinephrine Plasma Membrane Transport Proteins
Radiation-Sensitizing Agents
Treatment Outcome
Young Adult

authors with profiles

Susan L. Cohn